New Delhi, March 31: India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its development, according to a report released on Tuesday. This is due to strong policy support and a growing pipeline of innovation.The report by Endiya Partners said that the...
bioeconomy
biopharmaceuticals
biotech
clinical trials
drug development
gmp infrastructure
government funding
healthcare
india
innovation
pharmaceuticals
policy
r&d
research institutes
startup ecosystem
